Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with SCLC: final results from the non-interventional study NADIR 5. November 2020 Losem C, Maintz C, Schulz H, Lück A, Geßner C, Grebhardt S, et al. Oncol Res Treat. 2020;43(suppl 4)(200):328 https://www.iomedico.com/wp-content/uploads/2020/11/Potthoff_NADIR_DGHO2020.mp4 Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with NSCLC: Final results from the non-interventional study NADIR C Geßner, A Lück, H Schulz, C Losem, G Dresemann, S Grebhardt, J Harde, N Marschner, J Hipp, K Potthoff, 2020 Oncol Res Treat. 2020;43(suppl… Weiterlesen First results from INFINITY – A Registry on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology in Routine Clinical Practice U Martens, M Reiser, S Schirrmacher-Memmel, L Sellmann, T Decker, A Schneeweiss, M Schuler, F Bengsch, C Vannier, K Potthoff, N Marschner, B Kasenda, 2020… Weiterlesen